research The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
Avacopan is generally safe, with some minor side effects like nausea and fatigue.
Search
for
Sort by
Research
870-900 / 1000+ results 
research Compatibility of Cetirizine Hydrochloride, Dutasteride, Hydrocortisone Acetate, Nicotinamide, Progesterone, and Pyridoxine Hydrochloride in TrichoSolTM, A Natural Vehicle for Hair Solutions.
TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.
research Reminder of finasteride-related psychiatric AEs and sexual dysfunction
research SHOIR VA DRAMATURG
research Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
Supplemental testosterone may lower liver cancer risk in hepatitis C patients.
research 486 Molecular Mechanisms of Type II Spiral Ganglion Neuron Development
research 丹蒽醌對人類惡性黑色素瘤細胞株(A375.S2)誘發細胞週期停滯及細胞凋亡之影響
Danthron from Rhubarb causes melanoma cells to stop growing and die.
research Where WNT the Hair
The document's conclusion could not be found or understood.
research Analyzing the Effectiveness of Your Marketing Campaign
The document's conclusion cannot be provided because the document is not accessible or understandable.
research Message from the ISHRS 2018 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research Message from the ISHRS 2018 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research Message from the ISHRS 2018 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research Follow-up
research Message from the ISHRS 2018 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research Osteopontin Gene Polymorphisms rs1126616 C>T and rs1126772 A>G are Associated with Atopic Dermatitis in Polish Population
Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.
research A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.
research Incomplete Sjögren-Larsson Syndrome in Two Japanese Siblings?
research Compounded topical finasteride-related AEs
research Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma
A new green method accurately measures finasteride and tadalafil in drugs and plasma.
research Chapter 45: Hair Loss
research Additional file 1 of Rejuvenating senescent hair follicles: a novel conjugated linoleic acid based nanovesicle approach to treat androgenic alopecia
research Additional file 1 of Rejuvenating senescent hair follicles: a novel conjugated linoleic acid based nanovesicle approach to treat androgenic alopecia
research Optimizing finasteride chemoprevention
research Medico-Legal Corner
The document's conclusion cannot be summarized because the content is not accessible or understandable.
research Epidemiological profile of frontal fibrosing alopecia
research 42146 Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib
Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.
research CUTANEOUS T-CELL LYMPHOMA
The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.
research Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey
research Finasteride
research First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.